DIRS.INFO The most relevant business & tech news

☆ At my heaviest, I weighed 360 pounds, which got in the way of my job as a firefighter. I lost weight by paying attention to what I ate.
▼ + stars: | 2024-12-01 | by ( Jane Ridley | ) www.businessinsider.com time to read: +5 min

AdvertisementAt 360 pounds, Clark Valery felt less efficient in his role as a volunteer firefighter. The 38-year-old was motivated to lose weight after the death of a friend from a heart attack. This as-told-to essay is based on a conversation with Clark Valery, 38, an assistant manager at a pharmacy chain and volunteer firefighter from New York. Best of all, I feel more energetic and effective as a volunteer firefighter. I'd get to the ladder, and it would say the weight limit was 250 pounds.

Persons: Clark Valery, They're, they've, Valery, Clark Valery Lunch, I'm, It's, I've Organizations: McDonalds, KFC, Business Locations: New York

☆ Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continues
▼ + stars: | 2024-10-29 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +6 min

The startup says care for GLP-1 patients has become its most popular front door for new customers. AdvertisementLast spring, diabetes startup Omada Health said it wanted to help employers manage patients taking a blockbuster new class of weight-loss drugs. Omada Health's metabolic health program has now become the entry point for most new employers considering contracts with Omada Health, Duffy said. Launched in 2011, Omada provides virtual care for diabetes, hypertension, musculoskeletal care, and diabetes prevention, alongside obesity, to employers, health plans, and even health systems. The firm said GLP-1 drugs for obesity account for about 10% of all pharmacy spending.

Persons: —, Duffy, Omada, haven't, buzzy, Willis Towers Watson Organizations: Service, Omada Health, Business, Nordisk's Ozempic Locations: WeightWatchers, GLP

☆ Sima Sistani, who embraced Ozempic, is out as CEO of WeightWatchers
▼ + stars: | 2024-09-27 | by ( Jordan Valinsky | ) edition.cnn.com time to read: +2 min

New York CNN —WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two-year stint. “These medications have shown, and science has evolved to say, that living with obesity is a chronic condition. Winfrey joined the board in 2015 and bought a 10% stake, immediately giving the beleaguered company relevance. Tara Comonte, a WeightWatchers board member and a former CEO of Shake Shack, will become the interim CEO effective immediately, the company said in a release. Prior to joining the company in June 2023, she was the CEO of a fertility technology company.

Persons: Sima Sistani, ” Sistani, Oprah Winfrey, Winfrey, Tara Comonte, Comonte’s, ”, Thilo Semmelbauer Organizations: New, New York CNN, CNN, National Museum of, Shake Locations: New York

☆ WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
▼ + stars: | 2024-09-27 | by ( Geoff Weiss | ) www.businessinsider.com time to read: +3 min

WeightWatchers' CEO of roughly two years, Sima Sistani, is out. AdvertisementIt's been a bumpy year for WW International, the company also known as WeightWatchers. In a leadership shake-up Friday, the weight-loss company announced CEO Sima Sistani is stepping down after roughly two years — effective immediately — and board member Tara Comonte is stepping up to serve as interim chief. Sistani helped push the company into the weight-loss drug space in 2023 through the $106 million acquisition of telehealth platform Sequence — which is now called WeightWatchers Clinic, and which prescribes weight-loss drugs like Ozempic and Wegovy. The telehealth purchase marked something of a pivot from the group support meetings and calorie-tracking menus WeightWatchers is known for, though the company also launched a behavioral program for patients on Ozempic.

Persons: WeightWatchers, Sima Sistani, —, It's, Tara Comonte, Sima, Thilo Semmelbauer, Sistani, haven't, Comonte, Oprah Winfrey Organizations: Service, WW International, WeightWatchers, WeightWatchers Clinic, CNN, Life Sciences, Shake, Business, Smithsonian's National Museum of

☆ A woman who lost 200 pounds by making simple changes shared the 2 key lessons she learned about fat loss
▼ + stars: | 2024-06-20 | by ( Rachel Hosie | ) www.businessinsider.com time to read: +4 min

She told Business Insider that losing weight was educational and transformative in many ways. Mancuso learned how intertwined physical, mental, and emotional health are. She also realized her former lifestyle wasn't actually easier. Losing weight gave Mancuso 'fuller experiences'For years, Mancuso thought that continuing her sedentary, fast-food-heavy lifestyle was the easy option. Mental and physical health are intertwinedPreviously, Mancuso hadn't thought about every aspect of health being connected.

Persons: —, Leah Mancuso, Mancuso, dieter, Jenny Craig, Lily Photo, Tara Dunn Organizations: Service, Business Locations: Scottsdale , Arizona, rollercoasters

☆ Exclusive: A16z-backed Knownwell is buying AI-powered Alfie Health to supercharge its obesity care
▼ + stars: | 2024-06-20 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +6 min

With that market shaking out this year, one obesity care startup just scooped up another. Knownwell, which provides obesity-centered primary care and weight management, has acquired Y Combinator startup Alfie Health, Business Insider has learned exclusively. But many investors leaned away from backing obesity care startups as the virtual prescription-focused model clashed with medication shortages. AdvertisementKnownwell has taken a different approach to weight management, with in-person providers alongside its virtual care services, and primary care in addition to obesity care. Alfie HealthGetting obesity care rightBoyarsky Pratt founded Knownwell alongside Dr. Angela Fitch, the president of the Obesity Medicine Association and the former associate director of Massachusetts General Hospital's weight care center.

Persons: —, Alfie, Alexander Singh, Ozempic, Knownwell, It's, Andreessen Horowitz, Alfie Health, Y Combinator, Nina Capital, Brooke Boyarsky Pratt, Boyarsky Pratt, it's, Angela Fitch, Vineeta, Kindbody, Agarwala Organizations: Service, Health, Business, Alfie Health, Knownwell, Flare Capital Partners, Nina, Obesity Medicine Association, Massachusetts, Oak, Carbon Health Locations: WeightWatchers, Plenty, Needham , Massachusetts, Boston, Massachusetts, Rhode Island, New Hampshire, Dallas, Minneapolis

☆ A woman lost 200 pounds over 2 years. It started by walking for 10 minutes and eating one nutritious food a day.
▼ + stars: | 2024-06-10 | by ( Rachel Hosie | ) www.businessinsider.com time to read: +9 min

Mancuso started making small tweaks to her diet and lifestyle, stayed consistent, and the weight came off. Leah MancusoNow 188 pounds, Mancuso, a photographer based in Scottsdale, Arizona, feels like a new person. One nutritious food per dayInstead of trying to overhaul her whole diet, Mancuso started small by eating one nutritious food every day — the first was eggs. Nutrition-wise, Mancuso progressed from eating one nutritious food a day to keeping a food journal. She returned to Disneyland 200 pounds lighterIn December 2023, Mancuso went back to Disneyland nearly 200 pounds lighter than her previous visit.

Persons: —, Leah Mancuso, Mancuso, Wegovy, dieter, Jenny Craig, wouldn't, she'd, Taco Bell, Erica, Jon, Mancuso didn't, Tara Dunn, I'm Organizations: Service, Business, Taco, Nutrition Locations: Scottsdale , Arizona, WeightWatchers

In addition to Wegovy and Ozempic, the GLP-1 class includes Eli Lilly's highly popular weight loss drug Zepbound and diabetes treatment Mounjaro. VanGilder signed up nearly four years ago and started taking the weekly diabetes injection Ozempic specifically for weight loss. The big difference between Calibrate and prior weight loss efforts, VanGilder said, is that she doesn't feel like she's dieting. Calibrate is one of the only companies to regularly release reports detailing the results of its weight loss program. The federal Medicare program by law can't cover weight loss drugs unless the prescription is for another approved health benefit, such as diabetes or cardiovascular health.

Persons: Michael Siluk, Gray Beard, She'd, that's, Beard, wouldn't, She's, Ro, Goldman Sachs, Eli Lilly's, it's, Andrew Dudum, There's, Zachariah Reitano, Reitano, Wegovy, WeightWatchers, Gary Foster, Foster, Oprah Winfrey's, Kim Gradwell, Lee Smith, Jennifer VanGilder, she'd, Jenny Craig, VanGilder, I've, Kristin Baier, Rob MacNaughton, Ro's Reitano, we'd, Eli Lilly, Craig Primack, Primack, Hims, Dudum, We're Organizations: — Novo, UCG, Novo Nordisk, CNBC, Teladoc Health, World Health Organization, Food, WeightWatchers Clinic, Ursinus College, Asset Management Locations: Charlotte , North Carolina, U.S, Dudley , North Tyneside, Britain, Collegeville , Pennsylvania, Hims

☆ Nestlé is releasing a lineup of frozen food for people on Ozempic and other GLP-1 drugs
▼ + stars: | 2024-05-21 | by ( Jordan Valinsky | ) edition.cnn.com time to read: +4 min

New York CNN —Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people taking GLP-1 drugs, such as Ozempic, for weight loss. However, a recent study on Wagovy significantly reduced heart risk in addition to helping with weight loss. An example of Vital Pursuit food. It also made a $100 million-plus deal to buy Sequence, a telehealth business that offers virtual prescriptions to patients for these weight loss drugs where appropriate. Food companies, like Nestlé, are also bracing for GLP-1 consumers to buy fewer sugary snacks and drinks.

Persons: New York CNN — Nestlé, It’s, Morgan, Steve Presley, Neil Saunders, Nestlé, it’s “, Saunders, ”, “ Nestlé, Sesame, WeightWatchers, ” Saunders, CNN’s Nathaniel Meyersohn Organizations: New, New York CNN, North, GlobalData, Lean, CNN, Companies, Costco, Equinox Locations: New York

☆ Oprah Winfrey apologizes for being 'major contributor' to shaming diet culture and the 'wagon of fat' moment
▼ + stars: | 2024-05-11 | by ( Eve Crosbie | ) www.businessinsider.com time to read: +4 min

"I've been a steadfast participant in this diet culture. AdvertisementIn 1988, Oprah Winfrey appeared on her show pulling a wagon full of fat, representing the 67 pounds she had lost in four months. Now, Winfrey told the audience that she wants to support them in their shift toward self-acceptance and healthier mindsets. Oprah Winfrey discussed her history with weight loss culture during the three-hour live stream from Weight Watchers. Shortly after, the Oscar winner helmed the ABC televised special "Shame, Blame and the Weight Loss Revolution," which saw her discuss the growing popularity of weight loss drugs such as Ozempic, Mounjaro, and Wegovy.

Persons: —, Oprah Winfrey, Winfrey, I've, makeovers, We've, Sima Sistani Organizations: Service, Business, WW International, National Museum of, WeightWatchers, ABC

☆ Oprah Winfrey: I set an unrealistic standard for dieting
▼ + stars: | 2024-05-09 | by ( Nicole Goodkind | ) edition.cnn.com time to read: +4 min

New York CNN —Oprah Winfrey said on Thursday evening that she has long played a role in promoting unhealthy and unrealistic diets. I cannot tell you how many weight loss shows and makeovers I have done and they have been a staple since I’ve been working in television,” she said. Winfrey told People Magazine in December that she has added a “weight-loss medication to her regimen” but didn’t specify which drug. Winfrey and WeightWatchersWinfrey left the board of WeightWatchers, ending a nearly decade-long stint as a director of the beleaguered company, in February. “I will say that I was on the board at the time there were discussions about whether or not WeightWatchers would move into weight loss medications,” Winfrey said on Thursday.

Persons: Oprah Winfrey, ”, I’ve, makeovers, Winfrey, Rebel Wilson, Amber Riley, Sima Sistani, Sistani, WeightWatchers Winfrey, ” Winfrey, Oprah, WeightWatchers, ” WeightWatchers, Jimmy Kimmel, “ Organizations: New, New York CNN, YouTube, WeightWatchers, Magazine, National Museum of, Goldman Sachs Locations: New York

☆ GNC is redesigning stores to draw people taking Ozempic
▼ + stars: | 2024-04-29 | by ( Nathaniel Meyersohn | ) edition.cnn.com time to read: +3 min

The brand hopes a new strategy tailored to people taking GLP-1 drugs for weight loss will help draw customers into stores and grow its business. We can help,” advertises an overhead banner in GNC’s new GLP-1 “support section.”GNC's new GLP-1 support section is available in all 2,300 stores across the United States. JON SIMON/GNCDanish pharmaceutical company Novo Nordisk is reaping huge profits from creating and selling the hit GLP-1 products. JPMorgan researchers estimate that 30 million people may be taking GLP-1 drugs by 2030, or around 9% of the US population. GNC, which filed for bankruptcy in 2020 and closed more than 1,200 stores, is the latest brand to build a strategy around people taking GLP-1s.

Persons: New York CNN — GNC, GNC, ”, JON SIMON, WeightWatchers Organizations: New, New York CNN, Novo Nordisk, Pfizer, Roche, JPMorgan, Equinox Locations: New York, United States, Danish

☆ Costco begins offering Ozempic prescriptions to some members
▼ + stars: | 2024-04-02 | by ( Nicole Goodkind | ) edition.cnn.com time to read: +2 min

The warehouse retailer is now offering its US members access to prescriptions for GLP-1 weight loss drugs through its low-cost health care partner Sesame. Costco first partnered with Sesame, a direct-to-consumer health care marketplace that connects medical providers nationwide with consumers, last fall when it began offering its members online health checkups for as low as $29. “The number one search term of Costco members seeking primary care on Sesame was around weight loss,” Goldhill said in an interview with USA Today. JPMorgan researchers estimate that 30 million people may be taking GLP-1 drugs by 2030, or around 9% of the US population. It also made a $100 million-plus deal to buy Sequence, a telehealth business that can offer virtual prescriptions, where appropriate, to patients for these weight loss drugs.

Persons: Sesame, David Goldhill, ” Goldhill, WeightWatchers Organizations: New, New York CNN, Costco, USA, CNN, JPMorgan Locations: New York

☆ WeightWatchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
▼ + stars: | 2024-03-14 | by ( Eric Rosenbaum | ) www.cnbc.com time to read: +6 min

But since then WW shares have suffered heavy selling, dropping to a new 52-week low on Thursday. The stock, due to its debt load and short interest, as well as the general anxiety about the impact of the new weight loss drugs, is subject to heightened volatility. In the memo, Sistani told employees she wanted "to take a moment to address some of the breathless media coverage." WW shares closed at $1.87 on Thursday. It noted that WW was among companies from the weight loss industry involved in the TV event.

Persons: Oprah Winfrey, Sistani, Eli Lilly, Sima Sistani, Guggenheim, Oprah, Winfrey Organizations: CNBC, Nordisk, Guggenheim Partners, Guggenheim, WeightWatchers Clinic, FDA, WeightWatchers, National Museum of, ABC

☆ Oprah's WeightWatchers departure proves she still has the power to move the needle
▼ + stars: | 2024-03-01 | by ( Erin Snodgrass | ) www.businessinsider.com time to read: +4 min

On Thursday, WeightWatchers stock was worth $3.12 — down from a 2021 high of $40. WeightWatchers' value jumped by $700 million in just two days after Winfrey joined the company in 2015, with shares more than doubling. AdvertisementBut WeightWatchers and other weight loss companies have struggled in the recent Ozempic-era, as GLP1 medications become more accessible and commonplace. (Evidence suggests Winfrey's endorsement of GLP-1 medications sparked a spike in demand for them, as well. ) The statement said WeightWatchers' board of directors is supportive of Winfrey's proposal to donate her stock to the museum.

Persons: —, Winfrey's, Winfrey, Oprah Winfrey, Phil, Oz, Suze Orman, WeightWatchers, Semmelbauer Organizations: Service, Business, WW International, Magazine, National Museum of Locations: WeightWatchers

☆ Ozempic is coming for gyms. Here’s how they’re responding
▼ + stars: | 2024-03-01 | by ( Nathaniel Meyersohn | ) edition.cnn.com time to read: +5 min

New York CNN —America’s gyms are adjusting their strategies as more of their members take weight loss drugs. JPMorgan researchers estimate that 30 million people may be taking GLP-1 drugs by 2030, or around 9% of the US population. For now, GLP-1 medications are prohibitively expensive for most Americans, costing about $1,000 or more a month. (Ozempic has not been approved for weight loss by regulators, though Wegovy, a similar drug, has.) It also made a $100 million-plus deal to buy Sequence, a telehealth business that offers virtual prescriptions to patients for these weight loss drugs where appropriate.

Persons: ”, Simeon Siegel, Bahram Akradi, “, Amanda Edwards, ” Siegel, Rick Caro, Jaap Arriens, WeightWatchers Organizations: New, New York CNN, Boomers, JPMorgan, Fitness, BMO Capital Markets, Management, Industries Locations: New York, Ozempic, Barre, Southern California

☆ Big-name investors are betting AI gadgets could change the way we interact with tech
▼ + stars: | 2024-03-01 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +5 min

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. What's on deck:This story is available exclusively to Business Insider subscribers. The big storyAI (literally) in your pocketTech workers are criticizing Humane's hotly anticipated Ai pin. AdvertisementIn fact, heavy hitters like legendary investor Vinod Khosla believe that AI devices will completely change how we interact with technology. Humane's Ai Pin, which can project text onto users' hands and translate voice messages, didn't get a warm welcome when it launched late last year .

Persons: —, Oompa, I've, Willy Wonka, Elon Musk, Sam Altman, Humane's, Vinod Khosla, Samantha Stokes, Vishal Persaud, Khosla, Ai, didn't, Tim Cook, Salesforce's Marc Benioff, OpenAI's Sam Altman, Franck Robichon, Paul Krugman, shouldn't, we're, Wells, Bank of America's Merrill, Bitcoin, Tyler Le, maven, Alexei Navalny's, Dan DeFrancesco, Hallam Bullock, Jordan Parker Erb, George Glover Organizations: Service, Business, Humane, Khosla Ventures, Rabbit, Bank of America's, Wall, The New York Times, WW, SEC Locations: Franck, Wells Fargo, New York, London

☆ Oprah is leaving WeightWatchers’ board, sending stock tumbling 25%
▼ + stars: | 2024-02-29 | by ( Jordan Valinsky | ) edition.cnn.com time to read: +2 min

New York CNN —Oprah Winfrey is leaving the board of WeightWatchers, ending a nearly decade-long stint as a director of the beleaguered company that has faced sudden competition from Ozempic. WeightWatchers shares (WW) plunged 25% in premarket trading Thursday and would be down 85% for the past six months if the premarket losses hold. WeightWatchers has faced more competition recently from GLP-1 prescriptions drugs like Ozempic and Wegovy sometimes used for weight loss. Last year, WeightWatchers also made a $100 million-plus deal to buy Sequence, a telehealth business that offers virtual prescriptions to patients for these weight loss drugs where appropriate. Winfrey told People Magazine in December that she has added a “weight-loss medication to her regimen” but didn’t specify which drug.

Persons: Oprah Winfrey, Winfrey, ”, Oprah, Sima Sistani, WeightWatchers, ” Winfrey Organizations: New, New York CNN, Ozempic, National Museum of, WeightWatchers, Magazine Locations: New York, GLP

☆ Oprah has left WeightWatchers, sending stocks spiraling and spelling doom for the diet of our foremothers
▼ + stars: | 2024-02-29 | by ( Mia De Graaf | Rachel Hosie | ) www.businessinsider.com time to read: +7 min

Oprah Winfrey will not seek reelection to the board of WW International, known as WeightWatchers. It was a surprising time to jump on board — WeightWatchers had been shedding users, and its stock price was dwindling. AdvertisementDespite not naming the brand, there was an immediate spike in demand for GLP-1 medications — the popular new class of weight-loss drugs. That same day, WW added a weight-loss drug arm to its business, acquiring Sequence, a service that provides weight-loss drugs. AdvertisementLong-term, WW needs to find a new identityOver time, WW will benefit from being a purveyor of hard-to-access weight-loss drugs.

Persons: Oprah Winfrey, —, Oprah giveth, Oprah taketh, maven, Winfrey, — WeightWatchers, Axios, Oprah, Forbes, Craig, Alex Fuhrman, Winfrey's, We're, Atkins Organizations: WW International, Service, SEC, Guardian, People Magazine, MarketWatch, Mayo Clinic, Business, Smithsonian's National Museum of, CNBC, Slate Locations: GLP, WeightWatchers

☆ Thinking about taking new weight loss drugs? These are the big health risk decisions that will follow
▼ + stars: | 2024-02-28 | by ( Eric Rosenbaum | ) www.cnbc.com time to read: +6 min

In this article NOVO.B-DKLLYWWGWW Follow your favorite stocks CREATE FREE ACCOUNTAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. But will Americans trust the most iconic brand in the legacy weight-loss business to guide them into its future? "Big pharma was coming for weight loss, and if they didn't have a clinical angle, they would have run the risk of becoming an irrelevant company." "This is a new, incredibly powerful and effective class of pharmaceuticals that a lot of people will find help improve their health." watch nowRisks of overreliance on obesity drugs The risk is real that providers may use the medications and "forget about lifestyle," said John Batsis, an associate professor and nutrition expert at the University of North Carolina Chapel Hill's school of public health.

Persons: Eli Lilly’s, Brendan Mcdermid, Eli Lilly, —, Sima Sistani —, Sistani, Alex Fuhrman, Hallum, Fuhrman, Davidson, Linda Bolton Weiser, I've, Geoff Cook, Cook, John Batsis, Batsis Organizations: Reuters, Novo Nordisk, CNBC, Craig, pharma, University of North, University of North Carolina Chapel Locations: New York City, U.S, Herbalife, University of North Carolina

☆ How to access the new weight loss drugs
▼ + stars: | 2024-02-15 | by ( Andrea Kane | ) edition.cnn.com time to read: +7 min

(CNN) — By now, it is pretty clear that the new weight loss and diabetes medications have achieved blockbuster status. Unlike previous weight loss medications, they are pretty effective at helping people lose weight and keep it off — between around 15% to 20% of body weight — with relatively few side effects (although some people can’t tolerate them, and a fraction of patients experience more severe side effects). Zepbound, the newly approved weight loss drug from Eli Lilly, may be easier to find. “Otherwise, some physicians are prescribing older, generic weight loss medications that can be helpful for some patients.”These drugs are not right for everyoneFor many people, the cultural pressure to look a certain way is high. And join us next week on the Chasing Life podcast when we talk to WeightWatchers CEO Sima Sistani about whether these new weight loss drugs really signal the end of diet culture.

Persons: Sanjay Gupta ”, Eli Lilly, Goldman Sachs, Meg Tirrell John Nowak “, Meg Tirrell, Sanjay Gupta, ” Tirrell, “, ” Eli Lilly, Tirrell, ”, Sima Sistani Organizations: CNN, —, Trilliant Health, Novo Nordisk, US Food and Drug Administration, “, Nordisk, ”

☆ ‘Your Fat Friend:’ New documentary turns unflinching gaze towards anti-fatness
▼ + stars: | 2024-02-09 | by ( Issy Ronald | ) edition.cnn.com time to read: +10 min

Rusty could barely bring himself to say the word “fat” when filming for the documentary first began six years earlier. Under the pseudonym “Your Fat Friend,” she began blogging anonymously, spotlighting these ways in which the world makes life harder for fat people. “Just say fat,” Gordon says in an accompanying voiceover, reading aloud one of her essays. “Just say fat,” Gordon says in a voiceover in the film. There’s space for my parents to grow and change, there’s space for the audience to grow and change,” Gordon says.

Persons: Aubrey Gordon, Rusty, “, ”, ” Gordon, Jeanie Finlay, Gordon, Jeanie Finlay “ It’s, sidelong, —, Phil Sharp, ” Finlay, “ It’s, Aubrey, — Pam, Rusty —, Pam grapples, ” Jeanie Finlay “, Gordon’s, Finlay, “ I’ve, Darren Aronofsky’s, Hal ” —, I’m, Roxane Gay, Aidy Bryant, Annie Easton, Fatphobia, Kate Manne, Desiree Burch, Julie Murphy, Jennifer Aniston Organizations: CNN, SNL, Cornell University, Netflix Locations: Europe, Canada, Oregon, proofread, London, Fatness

☆ Ro, the $7 billion healthcare startup, has a high-stakes strategy to take off-brand Ozempic mainstream
▼ + stars: | 2024-02-07 | by ( ) www.businessinsider.com time to read: +11 min

The $7 billion healthcare startup Ro, which has been prescribing brand-name weight-loss shots since January 2023, now offers compounded semaglutide to patients enrolled in its weight-management program. Nonetheless, Ro is the first prominent healthcare company to effectively endorse compounded semaglutide by prescribing it. A poor-quality compounded drug might simply be a dud and a waste of money. But while compounding pharmacies are subject to FDA and state regulations, states are the main regulators, and their oversight is patchy. Michael Siluk/UCG/Universal Images Group via Getty ImagesIt's hard to know if any given vial of compounded semaglutide is safe.

Persons: Wegovy's, Ro, drugmakers, Eli Lilly's, Eli Lilly's Mounjaro, Scott Gottlieb, Michael Siluk, That's, they've, Ozempic, Eli Lilly, Eric Kastango, they're, Kastango, aren't, Al Carter, Sarah Jones Simmer, Spencer Nadolsky, WeightWatchers, Tim Church, Wondr, it's, hasn't Organizations: Business, Novo Nordisk's Wegovy, US Food and Drug Administration, FDA, Novo Nordisk's Ozempic, Getty, Novo Nordisk, USP, National Association of, Pharmacy, Health Locations: Novo, Massachusetts, Austria, New York City

☆ Opinion: We’ll finally get some answers from Iowa about Trump
▼ + stars: | 2024-01-14 | by ( Richard Galant | ) edition.cnn.com time to read: +18 min

It is a feat former President Donald Trump is trying to duplicate this year. The first true test of Trump’s comeback occurs Monday in Iowa, where caucusgoers will venture into sub-zero temperatures to choose between Trump, Florida Gov. After months of speculation, we’ll finally get some answers to a few questions: Is there an opening for any Republican aside from Trump? Most of our contributors thought Haley won Wednesday’s CNN debate in Iowa against DeSantis, but Trump’s absence from the stage again loomed large. “Haley sounded like someone looking to take on the genuine article — the Republican frontrunner,” wrote W. James Antle III.

Persons: George Washington’s, Grover Cleveland, ”, Troy Senik, Donald Trump, Cleveland, “, —, Republican frontrunner’s, Cleveland didn’t, Benjamin Harrison —, Ron DeSantis, Nikki Haley, Vivek Ramaswamy, we’ll, Will DeSantis, he’s, Haley, Wednesday’s, “ Haley, James Antle III, ’, ” Clay Jones, Chris Christie, Trump, ” Antle, who’s, Facebook Sophia, Nelson, “ Haley isn’t, Todd Graham, she’d, it’s, ” DeSantis, John Avlon, Laurence Tribe, Norman Eisen, Taylor Redd, Florence Pan, John Sauer, ” Bill Bramhall, Frida Ghitis, Ghitis, DeSantis, Julian Zelizer, Dean Obeidallah, Nikki Haley’s Lisa Benson, Peter Bergen, Prince Mohammed Bin Salman, Biden, ” Walt Handelsman, Max, Drew Sheneman, Hassan Shahidi, Shahidi, Oprah, Oprah Winfrey, John Salangsang, Adrienne Bitar, WeightWatchers, couldn’t, Rose Blanchard, Sarah Gundle, Blanchard, Claudine ‘ Dee Dee ’ Blanchard, Gypsy Rose, ” Dee Dee, Gundle, Dee Dee Blanchard, Pope Francis, ” Jill Filipovic, Filipovic, Pope, ” Lloyd Austin’s, Lloyd Austin, Joe Biden, Austin, isn’t, Bill Bramhall, “ Oppenheimer, “ Barbie, “ Barbie ”, Gene Seymour, Oppenheimer, Emma Stone, ” Seymour, Don’t, Michael Bociurkiw, Ukraine Lanhee J, Chen, Noah Berlatsky, Belichick Bill Belichick, Vince Lombardi, Jeff Haynes, Bill Belichick, Will Leitch, Jeff Pearlman, Nick Saban, ” “ Belichick, Saban, ’ Pearlman, Lou Piniella, ‘ Organizations: CNN, University of Michigan, Cleveland, Republican, Trump, Trump , Florida Gov, Wednesday’s CNN, DeSantis, New, New Jersey Gov, Twitter, Facebook, Florida Gov, DC, Agency, Capitol, GOP, US, UK, Alaska Airlines, Boeing, Max, Portland International, Flight, Foundation, Golden Globe, Globes, Catholic, Biden, Warner Bros ., Academy, Hollywood Foreign Press Association, Belichick, New England Patriots, Reliant, Patriots, Carolina Panthers, Getty, Super, Football, NFL, Minor League NFL, University of Alabama, Schlitz, Seattle Mariners Locations: Cleveland, Iowa, Trump , Florida, Trump, New Hampshire, New Jersey, Graham, Houthi, Yemen, Red, “, Saudi Arabia, Saudi, Bergen, Iran, Iraq, Iranian, Oregon, Beverly Hills , California, Ukraine, Houston , Texas, AFP, Swiss

☆ Opinion: What Oprah gets right about diet culture
▼ + stars: | 2024-01-11 | by ( Opinion Adrienne Bitar | ) edition.cnn.com time to read: +6 min

How could she, the queen of WeightWatchers and doyenne of dieting, be abandoning the equation of diet + exercise = slim? Taking weight-loss drugs, rejecting diet culture or choosing to diet are all valid health decisions. Just look at the tragic history of diet drugs. When considered in this context, semaglutide isn’t the weight loss panacea it may appear to be. Oprah and the millions of other Americans on prescription semaglutide and similar medications should be respected — or at least not ridiculed — for ignoring the insults and choosing what’s right for them, drug or no drug, diet or no diet.

Persons: Adrienne Bitar, ”, Oprah Winfrey, WeightWatchers, Oprah, couldn’t, Cancer, dieters, “, gaunt, Jimmy Kimmel, Atkins “, John Harvey Kellogg, Kellogg, dieter, — Organizations: “, Studies, Cornell University, CNN, ”, Federal Food

Search resuls for: "WeightWatchers"

25 mentions found